Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGLTS:0NQH 76 Buyback Yield % is 0.00 as of Aug. 03, 2026. GuruFocus rates LTS:0NQH with a GF Score™ of 76/100 and a GF Value™ of €13.65 (Fairly Valued). The stock has 3 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 369003.32% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Rhoen Klinikum AG's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0NQH vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG (LTS:0NQH) has a Buyback Yield % of 0.00 as of Aug. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rhoen Klinikum AG and its competitors. According to the industry distribution chart, Rhoen Klinikum AG ranks #999999 out of 271 companies in the Healthcare Providers & Services industry.
Is Rhoen Klinikum AG's Buyback Yield % too high?
Rhoen Klinikum AG's current Buyback Yield % is 0.00. Based on the distribution chart, Rhoen Klinikum AG ranks #999999 out of 271 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Rhoen Klinikum AG has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #999999 out of 271 companies for Buyback Yield %. This places Rhoen Klinikum AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rhoen Klinikum AG and its competitors. Rhoen Klinikum AG's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Based on GuruFocus' analysis, Rhoen Klinikum AG (LTS:0NQH) is currently considered Fairly Valued. The stock's GF Value™ is €13.65, compared to a current price of €12.70 — trading 7% below its estimated fair value. The current Buyback Yield % is 0.00. Rhoen Klinikum AG's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Rhoen Klinikum AG (LTS:0NQH), the current Buyback Yield % is 0.00 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (LTS:0NQH) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of €12.70 is trading 7% below its estimated GF Value™ of €13.65.
GuruFocus considers Rhoen Klinikum AG to be Fairly Valued.
Key valuation signals for LTS:0NQH:
Buyback Yield %: 0.00
GF Value™: €13.65 vs. price of €12.70 (7% below fair value)
No single metric tells the full story. See the LTS:0NQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
76GF Score
Get the complete analysis for LTS:0NQH
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0NQH has been successfully added to your 
